Pixalate Releases Q3 2025 Global Invalid Traffic (IVT) & Ad Fraud Benchmarks for Web, Mobile Apps, and CTV: Web IVT Rate 21%; Mobile App IVT Rate 33%; CTV IVT Rate 19%

Pixalate Releases Q3 2025 Global Invalid Traffic (IVT) & Ad Fraud Benchmarks for Web, Mobile Apps, and CTV: Web IVT Rate 21%; Mobile App IVT Rate 33%; CTV IVT Rate 19% According to Pixalate's research into invalid traffic (IVT), including ad fraud, in programmatic advertising across the United States (U.S.), Canada, the United Kingdom (UK), […]

Crown Racing joins the RACER Creator Awards as Content Category Sponsor

Somewhere a creator is cutting a midnight edit. Headlights crawl across a garage wall. A laptop fan whispers. A clip finds its place. On November 20, 2025, that kind of work met a stage at the RACER Creator Awards inside the Los Angeles Convention Center, presented in partnership with AutoMobility LA and the Los Angeles

Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Evommune, Inc. (“Evommune”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the closing of its initial public offering of 10,781,250 shares of common stock at an initial public offering price of $16.00 per share, which includes the exercise in full by the underwriters of their option

Lazydays Announces Plan to Delist from Nasdaq

Lazydays Holdings, Inc. (“Lazydays,” the “Company,” “we” or “our”) (NasdaqCM: GORV) today announced the Company's intention to delist its common stock (the “Common Stock”) from The Nasdaq Capital Market (“Nasdaq”). The Company anticipates the delisting will become effective on or about November 28, 2025, after the Company has completed requisite notifications to Nasdaq and the

Realty Income Announces 665th Consecutive Common Stock Monthly Dividend

Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced that it has declared its 665thconsecutive common stock monthly dividend. The dividend amount of$0.2695per share, representing an annualized amount of$3.234per share, is payable on December 15, 2025 to stockholders of record as of November 28, 2025. https://mma.prnewswire.com/media/122541/Realty_Income_Logo.jpg About Realty Income Realty Income

Bit Digital, Inc. Announces Date for Third Quarter 2025 Financial Results and Conference Call

Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”) today announced that it will release its financial results for the third quarter ended September 30, 2025, before the market opens on Friday, November 14, 2025. Senior management will host a live webcast and conference call to discuss the results at 9:00 a.m. Eastern Time

Biglari Holdings Inc. News Release

Biglari Holdings Inc. (NYSE: BH.A; BH) announces its results for the third quarter and first nine months of 2025. Biglari Holdings Inc.'s earnings for the third quarter and first nine months of 2025 and 2024 are summarized below. To become fully apprised of our results, shareholders should carefully study our 10-Q, which has been posted

InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria

(NASDAQ:IFRX), Company expects to host a webcast to discuss the topline data on Monday, November 10 at 8:00 AM EST / 2:00 PM CET Company also expects to publish third quarter 2025 financial results on the same day pre-market JENA, Germany, Nov. 07, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering

Real-World Evidence Studies of XPHOZAH(R) (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

(NasdaqGM:ARDX), WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company presented data, including results from the first real-world study of XPHOZAH, at American Society of Nephrology's

Arhaus Opens Its First Montana Showroom in Bozeman

(NASDAQ:ARHS), BOSTON HEIGHTS, Ohio, Nov. 07, 2025 (GLOBE NEWSWIRE) — Arhaus (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, today announced the opening of its new 12,006-square-foot showroom in Bozeman, Montana. Located in Gallatin Crossing–Bozeman's premier shopping and lifestyle destination surrounded by sweeping mountain views–the new showroom marks Arhaus'

Scroll to Top